Vanda Pharma: Q3 Earnings Insights

Comments
Loading...

Vanda Pharma VNDA reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Vanda Pharma missed estimated earnings by 100.0%, reporting an EPS of $0.0 versus an estimate of $-0.04.

Revenue was down $26.50 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.16 which was followed by a 8.05% drop in the share price the next day.

To track all earnings releases for Vanda Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

VNDA Logo
VNDAVanda Pharmaceuticals Inc
$4.33-0.92%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
34.56
Growth
-
Quality
-
Value
87.08
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: